Social phobia: Diagnosis, severity and implications for treatment

European Archives of Psychiatry and Clinical Neuroscience

Volumn 249, Issue SUPPL., 1999, Pages

  Montgomery, Stuart A ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Comorbidity; Moclobemide; Social phobia; SSRI

Indexed keywords

MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

ALCOHOL ABUSE; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DRUG ABUSE; DRUG EFFICACY; DRUG SAFETY; DYSTHYMIA; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; REVIEW; SOCIAL PHOBIA;

EID: 0032969739     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00014161     Document Type: Review

References (35)

1. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders (DSM-III-R). 3 Ed., Washington, APA
2. Black B, Uhde TW, Tancer ME (1992) Fluoxetine for the treatment of social phobia (letter). J Clin Psychiat 12: 293-295
3. Davidson JRT, Hughes DL, George LK, Blazer DG (1993) The epidemiology of social phobia, findings from the Duke Epidemiologic Catchment Area Study. Psycholog Med 23: 709-718
4. Davidson JRT, Potts N, Krishnan R, Ford S, Smith R, Wilson WH (1995) Treatment of social phobia with clonazepam. J Clin Psychopharmacol 13: 423-428
5. Eaton WW, Weissman M (1991) Panic and phobias. In: Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. Robins E, Regier DA (eds) New York, Free Press, pp 155-179
6. Fahlen T, Nilsson HL, Borg K, Humble M, Pauli U (1995) Social phobia: the clinical efficacy and tolerability of the monoamine oxidase-A and serotonin uptake inhibitor brofaromine. A double-blind placebo-controlled study. Acta Psychiatr Scand 92: 358
7. Gelernter CS, Uhde TW, Cimbolic P, Arnkoff DB, Vittone BJ, Tancer ME, Bartko JJ (1991) Cognitive-behavioral and pharmacological treatments of social phobia: a controlled study. Arch Gen Psychiatry 49:938-945
8. Heimberg RG, Liebowitz MR (1996) Design of trials in psychosocial treatment for social phobia. Int Clin Psychopharmacol 11: 55-64
9. Katzelnick DJ, Kobak KA, Greist JH (1995) Sertraline in social phobia: a double-blind, placebo-controlled crossover study. Am J Psychiatry 152: 1368-1371
10. Kelly D, Guirguis W, Frommer E, Mitchell-Heggs N, Sargeant W (1970) Treatment of phobic states with antidepressants. Br J Psychiatry 116: 387-398
11. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshelman S, Wittchen HO, Kendler KS (1994) Lifetime and 12 month prevalence of DSM III-R psychiatric disorders in the United States. Results from the National Cormorbidity Survey. Arch Gen Psychiatry 51: 8-19
12. Lecrubier Y, Weiller E (1997) Comorbidities in social phobia. Int Clin Psychopharmacol 12: 17-21
13. Lepine JP, Lellouch J (1995) Classification and epidemiology of social phobia. Eur Arch Psychiat Clin Neurosci 244: 290-296
14. Liebowitz MR, Gorman JM, Fyer AJ, Klein AF (1985) Social Phobia: Review of a neglected anxiety disorder. Arch Gen Psychiatry 42: 729-736
15. Liebowitz MR, Schneier FR, Campeas R, Hollander E, Hatterer J, Fyer AJ, Gorman JM, Papp L, Davies S, Gully R, Klein DF (1992) Phenelzine vs atenolol in social phobia: A placebo-controlled comparison. Arch Gen Psychiatry 49: 290-300
16. Magee WJ, Eaton WW, Wittchen H-U, McGonagel KA, Kessler RC (1996) Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry 53: 159-168
17. Merinkangas K, Angst J (1995) Comorbidity and social phobia: evidence from clinical, epidemiologic, and genetic studies. Eur Arch Psychiat Clin Neurosci 244: 297-303
18. Montgomery SA (1998) Implications of the severity of social phobia. J Affect Dis 50: 17-22
19. Noyes R, Moroz G, Davidson JR, Liebowitz MR, Davidson A, Siegel J, Bell J, Cain JW, Curlik SM, Kent TA, Lydiard RB, Mallinger AG, Pollack MH, Rapaport M, Rasmussen SA, Hedges D, Schweizer E, Uhlenhuth EH (1997) Moclobemide in social phobia: a controlled dose-response trial. J Clin Psychopharmacol 17: 247-254
20. Nutt D, Montgomery SA (1996) Moclobemide in the treatment of social phobia. Int Clin Psychopharmacol 11: 77-82
21. Robins LN, Regier DA (1990) Psychiatric disorders in America: The epidemiological catchment area study. New York, Free Press
22. Sanderson WC, Di Nardo PA, Rapee RM et al. (1990) Syndrome co-morbidity in patients diagnosed with a DSM-III-revised anxiety disorder. J Abnorm Psychol 99: 308-312
23. Schneier FR, Heckelman LR, Garfinkel R, Campeas R, Fallon BA, Gitow A, Street L, Del Bene D, Liebowitz MR (1994) Functional impairment in social phobia. J Clin Psychiat 55: 322-331
24. Schneier FR, Johnson J, Hornig CD, Liebowitz MR, Weissman MM (1992) Social phobia: Comorbidity and morbidity in an epidemiological sample. Arch Gen Psychiatry 49: 282-288
25. Sheehan DV, Harnett-Sheehan K, Raj BA (1996) The measurement of disability. Int Clin Psychopharmacol 11: 89-95
26. Van Ameringen M, Mancini C, Strainer DL (1993) Fluoxetine efficacy in social phobia. J Clin Psychiat 54: 27-32
27. Van Ameringen M, Mancini C, Streiner DL, Jeeves P (1994) Sertraline treatment in social phobia a pilot study. Neuropsychopharmacol 10: 117-172
28. van Vliet IM, den Boer JA, Westenberg HGM (1992) Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor. Eur Neuropsychopharmacol 2: 21-29
29. van Vliet IM, den Boer JA, Westenberg HGM (1994) Psychopharmacological treatment of social phobia: a double blind placebo controlled study with fluvoxamine. Psychopharmacol 115: 128-134
30. Versiani M, Amrein R, Montgomery SA (1997) Social phobia: long-term treatment outcome and prediction of response - a moclobemide study. Int Clin Psychopharmacol 12: 239-254
31. Versiani M, Mundim FD, Nardi AE, Liebowitz MR (1988) Tranylcypromine in social phobia. J Clin Psychopharmacol 8: 279-283
32. Versiani M, Nardi AE, Mundim FD, Alves AB, Liebowitz MR, Amrein R (1992) Pharmacotherapy of social phobia: a controlled study with moclobemide and phenelzine. Br J Psychiatry 161: 353-360
33. Wacker HR, Mullejans R, Klein KH, Battegay R (1992) Identification of cases of anxiety disorder and affective disorders in the community according to ICD-10 and DSM-III-R by using the Composite International Diagnostic Interview (CIDI). Int J Meth Psychiat Res 2: 91-100
34. Weiller E, Bisserbe JC, Boyer P, Lepine J-P, Lecrubier Y (1996) Social phobia in general health care: an unrecognised undertreated disabling disorder. Br J Psychiatry 168: 169-174
35. West ED, Dally PJ (1959) Effects of iproniazid in depressive syndromes. Br Med J: 1490-1499